Epidermal growth factor receptors and doxorubicin plus ifosfamide/mesna in recurrent breast cancer.
Cantwell
B M
BM
Hennessy
C
C
Millward
M J
MJ
Lennard
T W
TW
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage; D066246:ErbB Receptors / Q000032:analysis*; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D015080:Mesna / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*
D004317:Doxorubicin; D066246:ErbB Receptors; D015080:Mesna; D007069:Ifosfamide